sales@angenesci.com
Login | Register
logo
Structures Search
Home Other Building Blocks (2S)-2-Ethyl-8-methyl-1-thia-4,8-diazaspiro[4,5]decan-3-one

(2S)-2-Ethyl-8-methyl-1-thia-4,8-diazaspiro[4,5]decan-3-one

CAS No.:
503431-81-0
Catalog Number:
AG00DFDP
Molecular Formula:
C10H18N2OS
Molecular Weight:
214.3277
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
Product Description
Catalog Number:
AG00DFDP
Chemical Name:
(2S)-2-Ethyl-8-methyl-1-thia-4,8-diazaspiro[4,5]decan-3-one
CAS Number:
503431-81-0
Molecular Formula:
C10H18N2OS
Molecular Weight:
214.3277
MDL Number:
MFCD09265248
IUPAC Name:
(2S)-2-ethyl-8-methyl-1-thia-4,8-diazaspiro[4.5]decan-3-one
InChI:
InChI=1S/C10H18N2OS/c1-3-8-9(13)11-10(14-8)4-6-12(2)7-5-10/h8H,3-7H2,1-2H3,(H,11,13)/t8-/m0/s1
InChI Key:
PHOZOHFUXHPOCK-QMMMGPOBSA-N
SMILES:
CC[C@@H]1SC2(NC1=O)CCN(CC2)C
UNII:
8D3PZX7G73
Properties
Complexity:
236  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
1  
Defined Bond Stereocenter Count:
0
Exact Mass:
214.114g/mol
Formal Charge:
0
Heavy Atom Count:
14  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
214.327g/mol
Monoisotopic Mass:
214.114g/mol
Rotatable Bond Count:
1  
Topological Polar Surface Area:
57.6A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
1.4  
Literature
Title Journal
An adaptive first in man dose-escalation study of NGX267: statistical, clinical, and operational considerations. Journal of biopharmaceutical statistics 20090101
M1 muscarinic agonists target major hallmarks of Alzheimer's disease--an update. Current Alzheimer research 20071201
Drug shows promise for treatment of Alzheimer's disease. The Lancet. Neurology 20060401
M1 receptors play a central role in modulating AD-like pathology in transgenic mice. Neuron 20060302
M1 muscarinic agonists can modulate some of the hallmarks in Alzheimer's disease: implications in future therapy. Journal of molecular neuroscience : MN 20030101
AF150(S) and AF267B: M1 muscarinic agonists as innovative therapies for Alzheimer's disease. Journal of molecular neuroscience : MN 20020101
Properties